.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
MASAI RCT: 12% reduction in interval cancer rate using Transpara
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
New book from Joanna Stern highlights personal breast cancer journey
.png)
New book from Joanna Stern highlights personal breast cancer journey
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
Get involved this Breast Cancer Awareness Month
.png)
Get involved this Breast Cancer Awareness Month
Every October, Breast Cancer Awareness Month draws attention to early detection and breast cancer screening.
October 01, 2026
Radboudumc celebrates SPM's Nico Karssemeijer
Radboudumc celebrates SPM's Nico Karssemeijer
As he departs Radboudumc as a professor, three leaders reflect on the legacy and impact of Nico Karssemeijer as a teacher and mentor.
August 31, 2026
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
ScreenPoint Medical announces $16 million investment from existing partners and research grants to fuel growth and build toward personalized care.
April 17, 2026
ScreenPoint Medical's founders honored
.png)
ScreenPoint Medical's founders honored
Nico Karssemeijer and Sir Michael Brady honored for their notable achievements and contributions to healthcare and the sciences.
February 11, 2026
ScreenPoint Medical and Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite
.png)
ScreenPoint Medical and Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite
Ferrum Health will offer Transpara solutions through its Model Hub, helping radiologists increase breast cancer detection and improve their workflow
January 13, 2026
Our Top 5 in 2025
.png)
Our Top 5 in 2025
ScreenPoint Medical's top news, articles, blogs, and perspective from 2025.
January 01, 2026